Skip to search formSkip to main contentSkip to account menu

CYP2C9*5 Allele

Known as: CYP2C9, c.1080C>G, CYP2C9*5, CYP2C9, D360E 
Human CYP2C9*5 allele is located within 10q24 and is approximately 33 kb in length. This allele, a variant form of the CYP2C9 wild-type allele… 
National Institutes of Health

Related topics

Related topics

11 relations
10q24Decreased Biochemical ActivityIron ChelationLipid Metabolism

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future.
Coumarins such as warfarin are prescribed for prevention and treatment of thromboembolic disorders. Warfarin remains the most… 
2019
2019
Cases in Precision Medicine: The Role of Pharmacogenetics in Precision Prescribing
Key Summary Points Although evidence for the clinical utility of genotype-based warfarin therapy is conflicting, data exist to… 
2014
2014
Research Highlights: novel CYP2C9 genetic polymorphisms and assessment of their impact on hydroxylation capacity.
ISSN 1462-2416 10.2217/PGS.13.243 © 2014 Future Medicine Ltd Pharmacogenomics (2014) 15(3), 261–264 261 part of CYP2C9 is a… 
2009
2009
A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.
2007
2007
A CBS haplotype and a polymorphism at the MSR gene are associated with cardiovascular disease in a Spanish case-control study.
Review
2001
Review
2001
Identification and Functional Characterization of a New CYP 2 C 9 Variant ( CYP 2 C 9 * 51 ) Expressed among African Americans
CYP2C9 is a polymorphic gene for which there are four known allelic variants; CYP2C9*1, CYP2C9*2, CYP2C9*3, and CYP2C9*4. In the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)